A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

It plays a significant role in cervical cancer development by potentially influencing the persistence of HPV infection and the progression of precancerous lesions to invasive cervical cancer ...

With proper screening, vaccination, and awareness, we can significantly reduce cervical cancer cases. It is crucial to educate people because cervical cancer is one of the few cancers in women that is ...

Periwinkle Technologies has developed the AI-enabled Smart Scope® CX for rapid, single-visit cervical examinations, ...

persistent hrHPV infection can progress to cervical cancer through the persistence and progression of cervical lesions. DARE-HPV is an investigational, proprietary fixed-dose formulation of ...

Cervical cancer ... viral genes even in advanced stages of disease, and repression of viral oncogene expression can prevent the growth and survival of cervical cancer cells The annual incidence ...

Sufficient scientific evidence exists to recommend HPV DNA testing in the triage of women with equivocal cytology and in follow-up after the treatment of precursor lesions. However, due to a low ...

Margaret Carpenter, based in New Paltz, New York, has been indicted for prescribing abortion pills to a person in Louisiana — ...

The cost of diagnosis of cancer, which can go up to Rs 50,000-60,000 is not included in the health insurance policies ...

Call the condition something else: abnormal cells, low-grade lesions ... cancer, are still called cancer. Others have already had the word excised from their names: Abnormal cervical cells ...

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.